Table 1 |
|
|
Characteristics at ART baseline: Adults |
|
| Total number of patients |
222 |
|
|
|
| Median age [IQR] (years) |
37.0 [32.0–43.0] |
| Female (%) |
153 (68.9) |
| BMI (kg/m2): N |
205 |
| Median [IQR] |
17.9 [16.4–19.4] |
| < 17 : n (%) |
70 (34.2) |
| 17–18.4 : n (%) |
54 (26.3) |
| ≥ 18.5 : n (%) |
81 (39.5) |
| CD4 done at initiation1: N |
176 |
| Median CD4 count [IQR] |
104.0 [39.5–172.0] |
| WHO clinical stage: N |
210 |
| Stage 4 (%) |
92 (43.8) |
| Stage 3 (%) |
112 (53.3) |
| Stage 1/2 (%) |
6 (2.9) |
| ART naïve2: n (%) |
211 (95.0) |
| Initial ART Regimen: N |
222 |
| 3TC+D4T+NVP |
168 (75.7) |
| 3TC+D4T+EFV |
32 (14.4) |
| Other |
22 (9.9) |
|
|
|
|
1 CD4 obtained between 3 months before and 1 month after ART are taken into account 2 Women who, before ART initiation, took PMTCT ARVs only are considered as naive IQR : interquartile range. |
|
|
O'Brien et al. Conflict and Health 2009 3:1 doi:10.1186/1752-1505-3-1 |
|
